Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Balance Bar -- Ignore unavailable to you. Want to Upgrade?

To: Tom Pulley who wrote (12)	7/16/1998 4:59:00 PM
From: Jonathan Boyd	Respond to of 49

Tom, thanks. Great post. The recent Hambrecht & Quist (H&Q) report agrees with much of what you say. Additionally (and encouragingly), H&Q feels that the stock is undervalued even with its high multiple. H&Q analysts Valette and Norton are forecasting what they consider to be conservative EPS of $.48 for CY'99. This would be 49% growth from this year's expected $.32 EPS. H&Q's 12 month target is $20. After noting that H&Q is the lead underwriter for B'bar and has every reason to promote the stock, I advise every current and potential investor in BBAR to get a copy of the H&Q report. Tom, Could you provide a short definition of HDL and LDL? Thanks, Jon